Dell has agreed to host Biosign Technologies' UFIT and Healthanywhere platforms on a global basis.
Biosign Technologies provides biomedical systems such as intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication.
The UFIT medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring.
The UFIT medical platform is currently only available in Europe, the MENA Region, and Canada.
Biosign’s Healthanywhere System is for the collection, transmission, and persistence of medical measurement data and patient care data for the encouragement and tracking of a patient’s progress against the goals set between the Healthcare Professional and the patient in the pursuit of providing care for a chronic or post-acute condition and/or to promote patient wellness.
Healthanywhere is available worldwide.
Biosign Technologies CEO Peter Tassiopoulos said with Dell’s ability to globally manage data centers, unified networks and architecture made it a natural choice for Biosign to partner with Dell for managing our distributed IT environment.
Dell Services Healthcare & Life Sciences VP and GM Berk Smith said both the companies recognize and seek to leverage the power of the cloud to provide meaningful global healthcare solutions to users around the globe.